Biotech Growth trust NAV up 10% despite 'very difficult period'

Outperforms its benchmark

clock • 2 min read

The Biotech Growth Trust has reported its net asset value rose 9.6% in the six months to the end of September after “a very difficult period”.

The results meant the trust beat the NASDAQ Biotechnology Index, its benchmark, which returned 6.8% during the same time. Price per share for the trust, which is co-managed by Geoffrey C. Hsu, increased to 994p, up from 898p at the end of March. The discount of share price to NAV per share is 5.3%, down from 6.3%. When combined with the increase in NAV, this reduction in the discount contributed to a share price return over the six months of 10.7%. A number of factors contributed to improvements in the trust's performance, including increased levels of merger and acquisition act...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment Trusts

PHP ends months long Assura bidding saga beating out private equity consortium offer

PHP ends months long Assura bidding saga beating out private equity consortium offer

Board switches previous shareholder recommendation

Eve Maddock-Jones
clock 23 June 2025 • 2 min read
European Assets trust agrees to combination terms with ESCT

European Assets trust agrees to combination terms with ESCT

EAT to hold AGM on Tuesday (24 June)

Sorin Dojan
clock 23 June 2025 • 2 min read
'Pressure on the board' at VEIL as 41% opt to wind up trust

'Pressure on the board' at VEIL as 41% opt to wind up trust

Performance has been tricky

Linus Uhlig
clock 20 June 2025 • 2 min read
Trustpilot